281 related articles for article (PubMed ID: 21820768)
1. Quinonoid and phenazine compounds: synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis.
Carneiro PF; Pinto Mdo C; Coelho TS; Cavalcanti BC; Pessoa C; de Simone CA; Nunes IK; de Oliveira NM; de Almeida RG; Pinto AV; de Moura KC; da Silva PA; da Silva Júnior EN
Eur J Med Chem; 2011 Sep; 46(9):4521-9. PubMed ID: 21820768
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-tubercular activity of novel alkyl substituted riminophenazine derivatives.
Li YL; Zhang CL; Zhang DF; Lu Y; Wang B; Zheng MQ; Li C; Yin DL; Huang HH
Yao Xue Xue Bao; 2012 Jun; 47(6):745-54. PubMed ID: 22919722
[TBL] [Abstract][Full Text] [Related]
5. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Trivedi A; Dodiya D; Surani J; Jarsania S; Mathukiya H; Ravat N; Shah V
Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
Ali MA; Yar MS; Kumar M; Pandian GS
Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.
Ortega MA; Sainz Y; Montoya ME; López De Ceráin A; Monge A
Pharmazie; 1999 Jan; 54(1):24-5. PubMed ID: 9987794
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of the antitubercular phenazine lapazine and development of PLGA and PCL nanoparticles for its entrapment.
Silveira N; Longuinho MM; Leitão SG; Silva RS; Lourenço MC; Silva PE; Pinto Mdo C; Abraçado LG; Finotelli PV
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():458-66. PubMed ID: 26478333
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration.
Dobrikov GM; Valcheva V; Stoilova-Disheva M; Momekov G; Tzvetkova P; Chimov A; Dimitrov V
Eur J Med Chem; 2012 Feb; 48():45-56. PubMed ID: 22154833
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of clubbed isopropylthiazole derived triazolothiadiazoles, triazolothiadiazines and mannich bases as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendra Prasad Y; Mallikarjuna BP; Chandrashekar SM
Eur J Med Chem; 2010 Nov; 45(11):5120-9. PubMed ID: 20797808
[TBL] [Abstract][Full Text] [Related]
11. 1,3-Azoles from ortho-naphthoquinones: synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis.
Moura KC; Carneiro PF; Pinto Mdo C; da Silva JA; Malta VR; de Simone CA; Dias GG; Jardim GA; Cantos J; Coelho TS; da Silva PE; da Silva EN
Bioorg Med Chem; 2012 Nov; 20(21):6482-8. PubMed ID: 23000294
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
13. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
[TBL] [Abstract][Full Text] [Related]
14. Comment on: isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
Köser CU; Summers DK; Archer JA
J Antimicrob Chemother; 2011 Mar; 66(3):686-7; author reply 687. PubMed ID: 21177677
[No Abstract] [Full Text] [Related]
15. Antitubercular agents. Part 1: synthesis of phthalimido- and naphthalimido-linked phenazines as new prototype antitubercular agents.
Kamal A; Hari Babu A; Venkata Ramana A; Sinha R; Yadav JS; Arora SK
Bioorg Med Chem Lett; 2005 Apr; 15(7):1923-6. PubMed ID: 15780634
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene)isonicotinohydrazide derivatives.
Lourenço MC; Ferreira Mde L; de Souza MV; Peralta MA; Vasconcelos TR; Henriques Md
Eur J Med Chem; 2008 Jun; 43(6):1344-7. PubMed ID: 17923172
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation.
Afanas'ev MV; Ikryannikova LN; Il'ina EN; Sidorenko SV; Kuz'min AV; Larionova EE; Smirnova TG; Chernousova LN; Kamaev EY; Skorniakov SN; Kinsht VN; Cherednichenko AG; Govorun VM
J Antimicrob Chemother; 2007 Jun; 59(6):1057-64. PubMed ID: 17442757
[TBL] [Abstract][Full Text] [Related]
19. Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).
Drowart A; Cambiaso CL; Huygen K; Serruys E; Portaels F; Jann E; Van Vooren JP
Int J Tuberc Lung Dis; 1997 Jun; 1(3):284-8. PubMed ID: 9432378
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1.
Lu X; Wan B; Franzblau SG; You Q
Eur J Med Chem; 2011 Sep; 46(9):3551-63. PubMed ID: 21641695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
